pyridostigmine

medication used to treat myasthenia gravis
rdfs:label
"pyridostigmine"@en
skos:altLabel
"Bromure de Pyridostigmine"@en
"Bromuro de piridostigmina"@en
"Mestinon®"@en
"Pyridostigmin bromid"@en
"Pyridostigmine"@en
"Pyridostigmini Bromidum"@en
"Regonol®"@en
schema:description
"medication used to treat myasthenia gravis"@en
schema:dateModified "2026-09-12T23:26:59+00:00"^^xsd:dateTime
schema:version 2544778136
wikibase:identifiers 32
wikibase:sitelinks 28
wikibase:statements 55
p:P10245 wd:statement/Q419472-d712588c-4943-47b0-abd2-ae6d77d5cc19
p:P10283 wd:statement/Q419472-54782F98-4853-413F-BE7F-C7D828E3F33B
wd:statement/Q419472-58D67C1D-A763-4B07-B94E-684B9639AF51
p:P11089 wd:statement/Q419472-DD4EDF1E-27C2-4DD7-9833-B03F515E94DE
p:P11143 wd:statement/Q419472-EF745E01-6BDB-4B81-A162-8FE8A88F63C4
p:P11198 wd:statement/Q419472-ED8004B5-E8BB-4479-BF97-050818318C63
p:P11199 wd:statement/Q419472-39319DF4-7230-4C63-8CCA-B97085D87306
p:P117 wd:statement/Q419472-c14e7719-4c30-5128-d386-84c7985dc2b1
p:P129 wd:statement/Q419472-2DA2750C-1B33-4AA4-BAFC-8B6CF7E31EED
wd:statement/Q419472-B700E102-716A-4253-B8AF-322B0FB3AD13
p:P1417 wd:statement/Q419472-F50B9CB1-0B55-4164-B504-67DBEDAE5933
p:P2057 wd:statement/Q419472-6C927B7D-7F90-484D-9FE5-37DEE0707187
p:P2067 wd:statement/Q419472-3A072BDF-7B05-4D6C-BAA8-C0ABF9113506
p:P2115 wd:statement/Q419472-2373493D-E60A-463E-AEE5-344F25EA77E1
p:P2175 wd:statement/Q419472-4B89AC2E-0199-40D6-8775-2E3A28985944
wd:statement/Q419472-8AA65128-BE64-47E8-B1D5-BB3F12CD0D69
p:P231 wd:statement/Q419472-90D89A36-A54A-4A82-9077-96900834C96F
p:P233 wd:statement/Q419472-F7800DC5-CD83-4FEC-BEDE-8D36A213B127
p:P234 wd:statement/Q419472-8A021ECF-44A8-445D-91EF-8243D02EBD24
p:P235 wd:statement/Q419472-FAA70F11-F3F7-4C67-8A94-887BF873290F
p:P267 wd:statement/Q419472-52b8c69d-45cb-1e53-d560-780b5ca3db56
p:P274 wd:statement/Q419472-2B43CECC-E703-4409-B0C5-7F362F35CADC
p:P279 wd:statement/Q419472-5ACD69F0-FB03-4E13-BD22-84075755C2FA
p:P2868 wd:statement/Q419472-9F241D65-DEFD-43EF-A0F3-D7620099BF4E
wd:statement/Q419472-DF85ACED-5BFB-4733-9431-29AC57318357
p:P2877 wd:statement/Q419472-B07D047A-0AB2-4AD9-B551-26F91C59CB34
p:P2892 wd:statement/Q419472-266B3301-8B5A-4D63-8CB5-D872C486332B
p:P31 wd:statement/Q419472-126C4F35-6E60-4FDA-9169-04599F2BD4C6
p:P3117 wd:statement/Q419472-B67416EE-C264-42FE-8222-99D66507FB79
p:P3345 wd:statement/Q419472-A1F9FA4A-03DB-4276-AB40-DDC3D5A756B6
p:P3489 wd:statement/Q419472-20BF2E49-5511-493B-B618-796CF071309B
wd:statement/Q419472-59DFD55C-A7A6-4538-953C-09F6F334811C
p:P366 wd:statement/Q419472-A88FF22A-89EF-4E30-BED1-0EB0C115A004
p:P373 wd:statement/Q419472-6fb086f0-4959-8b69-72ad-7a1e9a583ecf
p:P3780 wd:statement/Q419472-64618F41-D195-4DEB-AFEE-B7567E901C64
wd:statement/Q419472-AE4B0B01-BFBD-4FD9-8255-5E7FB56D6FFB
p:P4250 wd:statement/Q419472-5AE52CE8-F9BD-4FF1-A989-3A6D68F01986
p:P4527 wd:statement/Q419472-b76dacad-4cf2-1329-1780-3e4565aa737a
p:P527 wd:statement/Q419472-78F4CD31-7A71-437C-AB21-89F537B29655
wd:statement/Q419472-8D5A2E91-E946-4A8F-ACAD-510E11E24172
p:P592 wd:statement/Q419472-55C2816F-E01F-46BB-8B2B-327E97EFFAE7
p:P595 wd:statement/Q419472-54D264ED-5326-4C5D-9260-21B320EC6257
p:P636 wd:statement/Q419472-fbd69e00-44ff-4362-a495-cd479703d261
p:P6366 wd:statement/Q419472-25C8EC8C-1441-4FD5-AABD-100DC23B1488
p:P646 wd:statement/Q419472-5DA326DA-BE7A-4709-81AE-97E2558B35E1
p:P652 wd:statement/Q419472-3BC25F1E-8CC3-4A32-93D8-A9CADCA64D93
p:P661 wd:statement/Q419472-19760391-33E3-4F6B-B8F8-59795B35FD5B
p:P662 wd:statement/Q419472-B0C178F4-60CD-46C4-ACF9-7BB81F8A158E
p:P665 wd:statement/Q419472-D01DB43C-9691-4E63-B55D-7BA8EC06B467
p:P6694 wd:statement/Q419472-66F589DF-744C-444A-81D8-71BD1443BE26
p:P683 wd:statement/Q419472-07BEA5C4-5716-4409-BBF9-E312FC3DB3B9
p:P715 wd:statement/Q419472-0DC6EA03-3DF8-40C7-BD2F-EB5352466D31
p:P769 wd:statement/Q419472-EE3C56FF-56A5-4F54-8D0D-4651E625B096
p:P8494 wd:statement/Q419472-0D62A54C-709F-435C-B959-10E23C715B24
p:P9635 wd:statement/Q419472-D9E955E2-8AA7-4545-9C96-FBB88661E7E8
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000148006>
p:direct-normalized/P4527 <http://data.parliament.uk/terms/12335>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1115>
p:direct-normalized/P6366 <https://makg.org/entity/2779901103>
p:direct-normalized/P661 <http://rdf.chemspider.com/4817>
p:direct-normalized/P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4991>
p:direct-normalized/P665 <http://www.kegg.jp/entry/C07410>
p:direct-normalized/P6694 <http://id.nlm.nih.gov/mesh/M0018237>
p:direct-normalized/P683 <http://purl.obolibrary.org/obo/CHEBI_8665>
wdt:P10245 "a682229"
wdt:P10283 "C2779901103"
"C2910532367"
wdt:P11089 "56534"
wdt:P11143 "Pyridostigmine"
wdt:P11198 "2330"
wdt:P11199 "PD010140"
wdt:P117 <http://commons.wikimedia.org/wiki/Special:FilePath/Pyridostigmine.svg>
wdt:P129 acetylcholinesterase
butyrylcholinesterase
wdt:P1417 "science/pyridostigmine"
wdt:P2057 "HMDB0014685"
wdt:P2067 181.098^^xsd:decimal
wdt:P2115 "N0000148006"
wdt:P2175 myasthenia gravis
wdt:P231 "155-97-5"
wdt:P233 "C[N+]1=CC=CC(=C1)OC(=O)N(C)C"
wdt:P234 "InChI=1S/C9H13N2O2/c1-10(2)9(12)13-8-5-4-6-11(3)7-8/h4-7H,1-3H3/q+1"
wdt:P235 "RVOLLAQWKVFTGE-UHFFFAOYSA-N"
wdt:P267 "N07AA02"
wdt:P274 "C₉H₁₃N₂O₂⁺"
wdt:P279 chemical compound
wdt:P2868 acetylcholinesterase inhibitor
WHO essential medicines
wdt:P2877 "1317"
wdt:P2892 "C0034261"
wdt:P31 type of chemical entity
wdt:P3117 "DTXSID20165786"
wdt:P3345 "9000"
wdt:P3489 US pregnancy category C
Australian pregnancy category C
wdt:P366 medication
wdt:P373 "Pyridostigmine"
wdt:P3780 Mestinon
Regonol
wdt:P4250 10.0^^xsd:decimal
wdt:P4527 "12335"
wdt:P527 carbon
nitrogen
wdt:P592 "CHEMBL1115"
wdt:P595 "8994"
wdt:P636 oral administration
wdt:P6366 "2779901103"
wdt:P646 "/m/037ss9"
wdt:P652 "19QM69HH21"
wdt:P661 "4817"
wdt:P662 "4991"
wdt:P665 "C07410"
wdt:P6694 "M0018237"
wdt:P683 "8665"
wdt:P715 "DB00545"
wdt:P769 succinylcholine
wdt:P8494 "DTXCID3088277"
wdt:P9635 "204"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata